FORT MYERS, FL / ACCESSWIRE / July 28, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetics testing services, today announced its second-quarter results for the period ended June 30, 2020. Neogenics specializes in hormone management and counteracting the affects of aging to promote a youthful, healthy, and vigorous lifestyle.
Fort Myers, FL The… Aging, as well as emotional stress, diet, and genetic factors, can affect our health. Importantly, the site is a short drive from the existing NeoGenomics footprint in Fort Myers and remains in the vicinity of the Southwest Florida International Airport. The Florida Department of Economic Opportunity (“DEO”) and Lee County have agreed to support NeoGenomics’ expansion to encourage the company’s growth of high-paying jobs in a “high-impact sector” of the local economy. By optimizing testosterone, progesterone, estrogen, DHEA, thyroid hormone, and growth hormone levels to youthful ranges, correcting nutrition and implementing exercise, many symptoms and conditions can be alleviated, or possibly even prevented, promoting a healthier and more enjoyable life.The aging process can lead to conditions such as Osteoporosis, Heart Disease, fatigue, hot flashes, and irritability. Neogenics provides the proper treatments to counteract the negative affects of aging and to promote a youthful, healthy, and vigorous lifestyle. We will not offer a treatment plan or therapy unless it can be validated by medical evidence. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development.© 2020 NeoGenomics Laboratories, Inc.Forward-looking statements represent the Company's estimates only as of the date such statements are made (unless another date is indicated) and should not be relied upon as representing the Company's estimates as of any subsequent date.
Pricing does not include medications or lab fees. FT MYERS, FL / July 9, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that it intends to build a leading-edge cancer diagnostics testing facility and new global business headquarters in Fort Myers, Florida. Neogenics looks to optimize your health by reseting these levels. At Neogenics we regulate and restore your body's hormones to stimulate an active and healthy lifestyle.Neogenics is an age management practice that believes functional decline and debilitating illnesses that arise from what mainstream medicine considers “normal” aging can be successfully treated and appropriately prevented.
The Fort Myers-based clinical laboratory — specializing in genetic … The Fort Myers-based company has been on the upswing. *All of our treatments are based on and supported by peer reviewed medical studies.
NeoGenomics, Inc. specializes in cancer genetic testing and information services. NeoGenomics faced a tough second quarter amid the coronavirus pandemic. "As expected, second quarter financial results were … We do not take the place of your own physicians care, we augment it. The new facility, which will be located on a 14 acre parcel of land close to the intersection of Alico Road and Three Oaks Parkway, is expected to open in 2021. FORT MYERS, FL / ACCESSWIRE / July 28, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetics … The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. “It’s going to be great for us,” he said. The facility in Aliso Viejo, California, nee Clarient, has been recently acquired and still has most of the management from before the acquisition, so that facility likely is unaffected so far.